+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Muscle Relaxants Drug Market by Drug (Facial Muscle Relaxant, Neuromuscular Relaxant, Skeletal Muscle Relaxant), Distribution (Clinics, Drug Stores, Hospitals) - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968778
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Muscle Relaxants Drug Market size was estimated at USD 4.44 billion in 2023, USD 4.78 billion in 2024, and is expected to grow at a CAGR of 7.88% to reach USD 7.55 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Muscle Relaxants Drug Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Muscle Relaxants Drug Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Muscle Relaxants Drug Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abbvie Inc., Acorda Therapeutics, Inc., Amneal Pharmaceuticals, Inc., Endo International PLC, Hikma Pharmaceuticals PLC, Ipsen Biopharmaceuticals, Inc., Johnson & Johnson Services, Inc., Mallinckrodt PLC, Medtronic PLC, Orient Pharma Co., Ltd., Pfizer Inc., SteriMax Inc., Teva Pharmaceutical Industries Ltd., and Upsher-Smith Laboratories, LLC.

Market Segmentation & Coverage

This research report categorizes the Muscle Relaxants Drug Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug
    • Facial Muscle Relaxant
    • Neuromuscular Relaxant
    • Skeletal Muscle Relaxant
  • Distribution
    • Clinics
    • Drug Stores
    • Hospitals
    • Online Stores
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Muscle Relaxants Drug Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Muscle Relaxants Drug Market?
  3. What are the technology trends and regulatory frameworks in the Muscle Relaxants Drug Market?
  4. What is the market share of the leading vendors in the Muscle Relaxants Drug Market?
  5. Which modes and strategic moves are suitable for entering the Muscle Relaxants Drug Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Muscle Relaxants Drug Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of lower back pain and other musculoskeletal disorders
5.1.1.2. Surge in surgeries in geriatric population
5.1.1.3. Increasing healthcare expenditure
5.1.2. Restraints
5.1.2.1. Side effects associated with muscle relaxant drugs such as habituation and respiratory arrest
5.1.3. Opportunities
5.1.3.1. Growing R&D activities for the development of novel drugs with FDA approvals and strategic collaborations
5.1.3.2. Potential growth in emerging economies
5.1.4. Challenges
5.1.4.1. Counterfeit drugs in developing countries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Muscle Relaxants Drug Market, by Drug
6.1. Introduction
6.2. Facial Muscle Relaxant
6.3. Neuromuscular Relaxant
6.4. Skeletal Muscle Relaxant
7. Muscle Relaxants Drug Market, by Distribution
7.1. Introduction
7.2. Clinics
7.3. Drug Stores
7.4. Hospitals
7.5. Online Stores
8. Americas Muscle Relaxants Drug Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Muscle Relaxants Drug Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Muscle Relaxants Drug Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Abbvie Inc.
12.1.3. Acorda Therapeutics, Inc.
12.1.4. Amneal Pharmaceuticals, Inc.
12.1.5. Endo International PLC
12.1.6. Hikma Pharmaceuticals PLC
12.1.7. Ipsen Biopharmaceuticals, Inc.
12.1.8. Johnson & Johnson Services, Inc.
12.1.9. Mallinckrodt PLC
12.1.10. Medtronic PLC
12.1.11. Orient Pharma Co., Ltd.
12.1.12. Pfizer Inc.
12.1.13. SteriMax Inc.
12.1.14. Teva Pharmaceutical Industries Ltd.
12.1.15. Upsher-Smith Laboratories, LLC
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. MUSCLE RELAXANTS DRUG MARKET RESEARCH PROCESS
FIGURE 2. MUSCLE RELAXANTS DRUG MARKET SIZE, 2023 VS 2030
FIGURE 3. MUSCLE RELAXANTS DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MUSCLE RELAXANTS DRUG MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MUSCLE RELAXANTS DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MUSCLE RELAXANTS DRUG MARKET DYNAMICS
FIGURE 7. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 8. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 10. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. MUSCLE RELAXANTS DRUG MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. MUSCLE RELAXANTS DRUG MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. MUSCLE RELAXANTS DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. MUSCLE RELAXANTS DRUG MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MUSCLE RELAXANTS DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 6. MUSCLE RELAXANTS DRUG MARKET SIZE, BY FACIAL MUSCLE RELAXANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR RELAXANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MUSCLE RELAXANTS DRUG MARKET SIZE, BY SKELETAL MUSCLE RELAXANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 10. MUSCLE RELAXANTS DRUG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MUSCLE RELAXANTS DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 21. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 22. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 23. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 24. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 33. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 34. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 35. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 36. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 39. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 40. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 51. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 52. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 59. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 60. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 61. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 62. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 63. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 64. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 65. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 66. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 67. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 70. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 71. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 76. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 77. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 78. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 79. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 80. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 81. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 88. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 89. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 94. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 95. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 100. MUSCLE RELAXANTS DRUG MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 101. MUSCLE RELAXANTS DRUG MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. MUSCLE RELAXANTS DRUG MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Abbvie Inc.
  • Acorda Therapeutics, Inc.
  • Amneal Pharmaceuticals, Inc.
  • Endo International PLC
  • Hikma Pharmaceuticals PLC
  • Ipsen Biopharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt PLC
  • Medtronic PLC
  • Orient Pharma Co., Ltd.
  • Pfizer Inc.
  • SteriMax Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Upsher-Smith Laboratories, LLC

Methodology

Loading
LOADING...

Table Information